Hikal
HIKAL.NSPre-clinicalHikal is a diversified chemical company with a strong focus on the pharmaceutical and agrochemical sectors, operating as a key partner for global innovators and generic companies. With decades of experience, it has built significant capabilities in research, process development, and manufacturing of high-value intermediates and APIs. The company's strategy is centered on expanding its CDMO services, investing in new technologies, and strengthening its position in regulated markets. Its financial stability is underpinned by a long-standing public listing and a diversified customer base.
HIKAL.NS · Stock Price
Historical price data
AI Company Overview
Hikal is a diversified chemical company with a strong focus on the pharmaceutical and agrochemical sectors, operating as a key partner for global innovators and generic companies. With decades of experience, it has built significant capabilities in research, process development, and manufacturing of high-value intermediates and APIs. The company's strategy is centered on expanding its CDMO services, investing in new technologies, and strengthening its position in regulated markets. Its financial stability is underpinned by a long-standing public listing and a diversified customer base.
Technology Platform
Expertise in complex chemical synthesis, process development, and scale-up manufacturing for pharmaceuticals and agrochemicals, serving as a Contract Development and Manufacturing Organization (CDMO).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Hikal competes with large Indian CDMOs like Divi's Laboratories and Syngene International, as well as global players. Its differentiation lies in deep expertise in complex chemical synthesis, a diversified business across pharma and agrochemicals, and long-standing relationships with multinational clients.
Company Info
Trading
Contact
Therapeutic Areas
Sectors
Partners
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile